OTCMKTS:CZMWY Carl Zeiss Meditec (CZMWY) Stock Price, News & Analysis → Radical change coming — do this NOW to protect yourself (From Weiss Ratings) (Ad) Free CZMWY Stock Alerts $73.22 -17.07 (-18.91%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$71.92▼$74.6650-Day Range$73.22▼$115.9052-Week Range$71.92▼$134.60Volume12,820 shsAverage Volume1,226 shsMarket CapitalizationN/AP/E Ratio79.59Dividend Yield0.41%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort Interest Get Carl Zeiss Meditec alerts: Email Address Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. About Carl Zeiss Meditec Stock (OTCMKTS:CZMWY)Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.Read More CZMWY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CZMWY Stock News HeadlinesMay 6, 2024 | finance.yahoo.comDeclining Stock and Solid Fundamentals: Is The Market Wrong About Carl Zeiss Meditec AG (ETR:AFX)?April 22, 2024 | finance.yahoo.comWhat Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?March 25, 2024 | finance.yahoo.comCarl Zeiss Meditec's (ETR:AFX) investors will be pleased with their respectable 63% return over the last five yearsMarch 21, 2024 | msn.comCarl Zeiss Meditec AG goes ex dividend tomorrowFebruary 29, 2024 | finance.yahoo.comInstitutions own 23% of Carl Zeiss Meditec AG (ETR:AFX) shares but private companies control 59% of the companyFebruary 13, 2024 | finance.yahoo.comCarl Zeiss Meditec AG (CZMWY)January 26, 2024 | seekingalpha.comCarl Zeiss: We've Seen Outperformance, But I See More Upside PotentialJanuary 11, 2024 | finanznachrichten.deCarl Zeiss Meditec AG: U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISSDecember 19, 2023 | msn.comCarl Zeiss Meditec to acquire Dutch Ophthalmic for around $1.08BDecember 18, 2023 | finance.yahoo.comCarl Zeiss Meditec Full Year 2023 Earnings: EPS Beats ExpectationsDecember 15, 2023 | markets.businessinsider.comEQS-News: Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)December 15, 2023 | markets.businessinsider.comEQS-Adhoc: Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.December 15, 2023 | finance.yahoo.comCarl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)December 15, 2023 | finance.yahoo.comZeiss Meditec buys Dutch firm for nearly 1 bln eurosNovember 27, 2023 | finance.yahoo.comAre Strong Financial Prospects The Force That Is Driving The Momentum In Carl Zeiss Meditec AG's ETR:AFX) Stock?November 13, 2023 | finance.yahoo.comShould You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €84.52?October 24, 2023 | msn.comCarl Zeiss Meditec: Premiums Are Proven To Be Dicey In This MarketSeptember 23, 2023 | fool.comCarl Zeiss Meditec Ag (ETR: AFX)September 5, 2023 | finance.yahoo.comEstimating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)August 8, 2023 | msn.comCarl Zeiss Meditec: One Of The Highest Premiums I'll AcceptJuly 28, 2023 | seekingalpha.comCZMWF Carl Zeiss Meditec AGJuly 4, 2023 | finance.yahoo.comThere's Been No Shortage Of Growth Recently For Carl Zeiss Meditec's (ETR:AFX) Returns On CapitalJune 16, 2023 | fool.comCarl Zeiss Meditec Ag (OTC: CZMWF)June 6, 2023 | finance.yahoo.comShould You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?April 12, 2023 | finance.yahoo.comInstitutions own 22% of Carl Zeiss Meditec AG (ETR:AFX) shares but private companies control 59% of the companySee More Headlines Receive CZMWY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 4/9 Dividend3/21/2024Ex-Dividend for 4/10 Dividend3/22/2024Dividend Payable4/09/2024Dividend Payable4/10/2024Today6/17/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:CZMWY CUSIPN/A CIKN/A Webwww.zeiss.com Phone493641220115FaxN/AEmployees4,823Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio79.59 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesDr. Markus WeberCEO & Chairman of Management BoardMr. Justus Felix Wehmer (Age 59)CFO & Member of the Management Board Comp: $650.23kDr. Christian Munster (Age 53)Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board Stefanie SpanagelChief Operating OfficerMr. Sebastian FrericksDirector of Investor RelationsEva-Maria HeineChief Human Resources OfficerMr. Steven C. Schallhorn M.D.Chief Medical Officer for Global Ophthalmic DevicesMr. Andrew ChangHead of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc.Dr. Euan S. Thomson Ph.D. (Age 61)President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit Mr. Magnus ReibenspiessHead of the Microsurgery Strategic Business Unit - ZEISS Medical TechnologyMore ExecutivesKey CompetitorsAddLife AB (publ)OTCMKTS:ADDLFAnsellOTCMKTS:ANSLYAnsellOTCMKTS:ANSLFAsahi InteccOTC:AHICFBATM Advanced CommunicationsOTCMKTS:BTAVFView All Competitors CZMWY Stock Analysis - Frequently Asked Questions Should I buy or sell Carl Zeiss Meditec stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Carl Zeiss Meditec in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CZMWY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CZMWY, but not buy additional shares or sell existing shares. View CZMWY analyst ratings or view top-rated stocks. How have CZMWY shares performed in 2024? Carl Zeiss Meditec's stock was trading at $109.1439 on January 1st, 2024. Since then, CZMWY stock has decreased by 32.9% and is now trading at $73.22. View the best growth stocks for 2024 here. Are investors shorting Carl Zeiss Meditec? Carl Zeiss Meditec saw a drop in short interest during the month of May. As of May 31st, there was short interest totaling 400 shares, a drop of 50.0% from the May 15th total of 800 shares. Based on an average daily trading volume, of 3,000 shares, the days-to-cover ratio is currently 0.1 days. View Carl Zeiss Meditec's Short Interest. How often does Carl Zeiss Meditec pay dividends? What is the dividend yield for Carl Zeiss Meditec? Carl Zeiss Meditec announced a dividend on Tuesday, February 27th. Stockholders of record on Monday, March 25th will be paid a dividend of $0.8282 per share on Wednesday, April 10th. The ex-dividend date of this dividend is Friday, March 22nd. Read our dividend analysis for CZMWY. Is Carl Zeiss Meditec a good dividend stock? Carl Zeiss Meditec (OTCMKTS:CZMWY) pays an annual dividend of $0.30 per share and currently has a dividend yield of 1.36%. The dividend payout ratio is 32.64%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for CZMWY. How do I buy shares of Carl Zeiss Meditec? Shares of CZMWY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CZMWY) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carl Zeiss Meditec AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Carl Zeiss Meditec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.